Top

Published in:

01-09-2012 | Letter to the Editors

NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease

Authors: Graham Mackay, Kate Ahmad, Jon Stone, Cathie Sudlow, David Summers, Richard Knight, Robert Will, Sarosh R. Irani, Angela Vincent, Paul Maddison

Published in: Journal of Neurology | Issue 9/2012

Excerpt

Dear Sirs, …

Available only for authorised users

Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, Baehring JM, Shimazaki H, Koide R, King D, Mason W, Sansing LH, Dichter MA, Rosenfeld MR, Lynch DR (2007) Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25–36PubMedCrossRef

Flanagan EP, McKeon A, Lennon VA, Boeve BF, Trenerry MR, Tan KM, Drubach DA, Josephs KA, Britton JW, Mandrekar JN, Lowe V, Parisi JE, Pittock SJ (2010) Autoimmune dementia: clinical course and predictors of immunotherapy response. Mayo Clin Proc 85:881–897PubMedCrossRef

Geschwind MD, Tan KM, Lennon VA, Barajas RF Jr, Haman A, Klein CJ, Josephson SA, Pittock SJ (2008) Voltage-gated potassium channel autoimmunity mimicking creutzfeldt-jakob disease. Arch Neurol 65:1341–1346PubMedCrossRef

Spencer MD, Knight RS, Will RG (2002) First hundred cases of variant Creutzfeldt-Jakob disease: retrospective case note review of early psychiatric and neurological features. BMJ (Clinical research ed) 324:1479–1482CrossRef

Irani SR, Bera K, Waters P, Zuliani L, Maxwell S, Zandi MS, Friese MA, Galea I, Kullmann DM, Beeson D, Lang B, Bien CG, Vincent A (2010) N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655–1667PubMedCrossRef

Irani SR, Vincent A (2011) NMDA receptor antibody encephalitis. Curr Neurol Neurosci Rep. doi:10.1007/s11910-011-0186-y PubMed

Sassoon J, Daniels M, Brown DR (2004) Astrocytic regulation of NMDA receptor subunit composition modulates the toxicity of prion peptide PrP106-126. Mol Cell Neurosci 25:181–191PubMedCrossRef

Ratte S, Prescott SA, Collinge J, Jefferys JG (2008) Hippocampal bursts caused by changes in NMDA receptor-dependent excitation in a mouse model of variant CJD. Neurobiol Dis 32:96–104PubMedCrossRef

Dalmau J, Lancaster E, Martinez-Hernandez E, Rosenfeld MR, Balice-Gordon R (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10:63–74PubMedCrossRef

10.

Ferrer I, Puig B (2003) GluR2/3, NMDAepsilon1 and GABAA receptors in Creutzfeldt-Jakob disease. Acta Neuropathol 106:311–318PubMedCrossRef

11.

Murray K (2011) Creutzfeldt-Jacob disease mimics, or how to sort out the subacute encephalopathy patient. Pract Neurol 11:19–28PubMedCrossRef

12.

Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, Dessain SK, Rosenfeld MR, Balice-Gordon R, Lynch DR (2008) Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7:1091–1098PubMedCrossRef

13.

The National CJD surveillance unit (2011) Current data. http://www.cjd.ed.ac.uk. Accessed 22.9.11

14.

Appleby BS, Appleby KK, Crain BJ, Onyike CU, Wallin MT, Rabins PV (2009) Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants. Arch Neurol 66:208–215PubMedCrossRef

15.

Kovanen J (1993) Clinical characteristics of familial and sporadic Creutzfeldt-Jakob disease in Finland. Acta Neurol Scand 87:469–474PubMedCrossRef

16.

Will RG, Matthews WB (1984) A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970–79. I: clinical features. J Neurol Neurosurg Psychiatry 47:134–140PubMedCrossRef

17.

Green A, Sanchez-Juan P, Ladogana A, Cuadrado-Corrales N, Sanchez-Valle R, Mitrova E, Stoeck K, Sklaviadis T, Kulczycki J, Heinemann U, Hess K, Slivarichova D, Saiz A, Calero M, Mellina V, Knight R, van Duijn CM, Zerr I (2007) CSF analysis in patients with sporadic CJD and other transmissible spongiform encephalopathies. Eur J Neurol 14:121–124PubMedCrossRef

18.

Zerr I, Kallenberg K, Summers DM, Romero C, Taratuto A, Heinemann U, Breithaupt M, Varges D, Meissner B, Ladogana A, Schuur M, Haik S, Collins SJ, Jansen GH, Stokin GB, Pimentel J, Hewer E, Collie D, Smith P, Roberts H, Brandel JP, van Duijn C, Pocchiari M, Begue C, Cras P, Will RG, Sanchez-Juan P (2009) Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 132:2659–2668PubMedCrossRef

19.

Heath CA, Cooper SA, Murray K, Lowman A, Henry C, MacLeod MA, Stewart GE, Zeidler M, MacKenzie JM, Ironside JW, Summers DM, Knight RS, Will RG (2010) Validation of diagnostic criteria for variant Creutzfeldt-Jakob disease. Ann Neurol 67:761–770PubMedCrossRef

20.

Heath CA (2008) Thesis: clinical aspects of variant CJD in the UK: 1995–2005. University of Aberdeen, Aberdeen, pp 1–279

21.

Collie DA, Summers DM, Sellar RJ, Ironside JW, Cooper S, Zeidler M, Knight R, Will RG (2003) Diagnosing variant Creutzfeldt-Jakob disease with the pulvinar sign: MR imaging findings in 86 neuropathologically confirmed cases. Ajnr 24:1560–1569PubMed

22.

Binelli S, Agazzi P, Giaccone G, Will RG, Bugiani O, Franceschetti S, Tagliavini F (2006) Periodic electroencephalogram complexes in a patient with variant Creutzfeldt-Jakob disease. Ann Neurol 59:423–427PubMedCrossRef

Title: NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease
Authors: Graham Mackay
Kate Ahmad
Jon Stone
Cathie Sudlow
David Summers
Richard Knight
Robert Will
Sarosh R. Irani
Angela Vincent
Paul Maddison
Publication date: 01-09-2012
Publisher: Springer-Verlag
Published in: Journal of Neurology / Issue 9/2012
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-012-6489-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

NMDA receptor autoantibodies in sporadic Creutzfeldt-Jakob disease

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 9/2012

Patterns of white matter diffusivity abnormalities in Leber’s hereditary optic neuropathy: a tract-based spatial statistics study

Natalizumab treatment of multiple sclerosis in Spain: results of an extensive observational study

Migraine with aura in patients over 50 years of age: the Marseille’s registry

Subacute progressive ophthalmoplegia associated with dermatomyositis

Clinical impact and predictors of carotid artery in-stent restenosis

Lobar cerebral microbleeds associated with transient focal neurological symptoms followed by symptomatic intracerebral hemorrhage